No drug in this class is approved to treat patients with dementia-related psychosis.
这种类型的药物中,没有一种被批准用于治疗痴呆相关的精神病性障碍的病人。
This remains the case, even though the FDA has warned their use may be associated with an increased risk of death among the elderly with dementia-related psychosis.
这仍是现实,即使FDA已经警告他们的应用与伴痴呆相关精神病的老年人死亡风险增高有关。
应用推荐